Welcome to our dedicated page for AKANDA news (Ticker: AKAN), a resource for investors and traders seeking the latest updates and insights on AKANDA stock.
Akanda Corp (AKAN) delivers medical cannabis solutions through regulated cultivation and innovative technology integration. This news hub provides investors and stakeholders with essential updates on the company's operations across three core segments: EU-GMP certified cannabis production, UK distribution via CanMart, and corporate strategy implementation.
Access timely press releases covering earnings reports, regulatory compliance milestones, partnership announcements, and technological advancements including blockchain supply chain initiatives and AI-driven operational improvements. Our curated collection ensures transparent tracking of AKAN's progress in pharmaceutical-grade cannabis production and international market expansion.
Bookmark this page for verified updates on cultivation facility developments, distribution network growth, and corporate governance changes. All content undergoes rigorous verification to maintain compliance with financial disclosure standards and medical cannabis regulations.
Akanda Corp (NASDAQ: AKAN) announced a settlement agreement with former CEO Tejinder Virk. This settlement concludes disputes that began after Virk's resignation on February 3, 2023. The agreement resolves all outstanding claims and disputes, allowing both parties to focus on future endeavors. CEO Katharyn Field stated that the decision to settle is in the company's best interest, enabling them to allocate resources to strategic priorities without any distractions. The agreement includes a waiver of all claims related to Virk's employment and termination.
Akanda Corp. announces plans to capitalize on the pending landmark change in US drug policy to reschedule cannabis under the Controlled Substances Act, potentially leading to significant market opportunities. The company aims to become a leader in consolidating US-based operators, following the DEA's proposal to reclassify cannabis as a Schedule III substance.
FAQ
What is the current stock price of AKANDA (AKAN)?
What is the market cap of AKANDA (AKAN)?
